P2.03-25 Loss of Expression Rather Than Cytoplasmic Mislocalization of RUNX3 Predicts Worse Outcome in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

The Low Expression of miR-451 Predicts a Worse Prognosis in Non-Small Cell Lung Cancer Cases

PLoS ONE
Multidisciplinary
2017English

P2.01-13 Number, Rather Than Location of Metastases, Dictates Outcome in Stage IV, M1b, Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Loss of FHIT Protein Expression Is Related to High Proliferation, Low Apoptosis and Worse Prognosis in Non-Small-Cell Lung Cancer

Modern Pathology
Forensic MedicinePathology
2004English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

P2.03-05 Biologic Profiling of Brain Metastasis From Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MicroRNA-661 Promotes Non-Small Cell Lung Cancer Progression by Directly Targeting RUNX3

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy